Fig. 1

Cardiovascular mortality in those with the first quartile versus those with the highest quartile of TSP-1 in plasma during a follow-up of 7.9 years. Note: Censored participants were those still living at the end of the study period, or who had died for reasons other than cardiovascular disease. Completed participants were those who had died due to cardiovascular disease